Evaluation of the genetic effects of 238Pu incorporated into mice. 1989

M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
N.I. Vavilov Institute of General Genetics, U.S.S.R. Academy of Sciences, Moscow.

The genetic effects of 238Pu incorporated into male mice were estimated by several tests. The activity of the administered 238Pu nitrate varied from 7 to 1850 Bq/g of body weight. The average alpha-radiation dose absorbed in the testes ranged from 2 to 96 cGy, with a dose rate of 0.004-1 cGy/day. alpha-Radiation from 238Pu was shown to induce dominant lethal mutations (DLM) and reciprocal translocation (RT), chromosomal fragmentation and formation of abnormal sperm heads (ASH). The effect does not depend on the average alpha-radiation dose absorbed in the testis. The relative genetic efficiency of alpha-radiation, as compared with that of chronic alpha-radiation for the indices under study, was about 10-20.

UI MeSH Term Description Entries
D008297 Male Males
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011005 Plutonium A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005260 Female Females
D005313 Fetal Death Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH. Fetal Mummification,Fetal Demise,Death, Fetal,Deaths, Fetal,Demise, Fetal,Fetal Deaths,Mummification, Fetal
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear

Related Publications

M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
January 1987, Radiobiologiia,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
April 1988, Genetika,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
January 2020, Journal of applied oral science : revista FOB,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
January 1980, Radiobiologiia,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
January 1963, Nature,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
January 1984, Radiobiologiia,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
January 2015, Dental materials journal,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
November 2017, Nanomedicine (London, England),
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
April 2006, The AAPS journal,
M D Pomerantseva, and L K Ramaya, and V A Shevchenko, and G A Vilkina, and A M Lyaginskaya
January 2009, Nucleic acids symposium series (2004),
Copied contents to your clipboard!